Recombinant human erythropoietin (rHuEPO) in treatment of pure red cell aplasia after 2-chlorodeoxyadenosine therapy in the patient with chronic lymphocytic leukemia - case report;LECZENIE REKOMBINOWANA LUDZKA ERYTROPOETYNA (RHUEPO) WYBIORCZEJ APLAZJI CZERWONOKRWINKOWEJ W NASTEPSTWIE TERAPII 2-CHLORODEOKSYADENOZYNA CHOREJ NA PRZEWLEKLA BIALACZKE LIMFATYCZNA - OPIS PRZYPADKU

Acta Haematologica Polonica

Volumn 27, Issue 2, 1996, Pages 193-198

  Adamczyk Cioch, M B ^a   Dmoszynska, A ^a   Hus, I ^a   Legiec, W ^a   Jawniak, D ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

2 Chlorodeoxyadenosine; Chronic lymphocytic leukemia; Pure red cell aplasia; Recombinant human erythropoietin

Indexed keywords

CLADRIBINE; RECOMBINANT ERYTHROPOIETIN;

ADULT; ARTICLE; CANCER REGRESSION; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PURE RED CELL ANEMIA;

EID: 0029782008     PISSN: 00015814     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)